Eris Lifesciences Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Eris Lifesciences Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Eris Lifesciences Ltd.
Rating: 5
Author: Prabhudas Lilladhar

Keep track of all breaking news and updates on Eris Lifesciences Ltd. from all sources in a single place.

Load latest

Eris Lifesciences Ltd.

20 May 2025

1615.40

-0.77%

Eris Lifesciences (ERIS IN) Q4FY25 Result Update Multiple...

Buy: Eris Lifesciences Ltd.

Target

Prabhudas Lilladhar

Strong FY26 guidance with +15% revenue growth with 36% OPM. up 70% YoY). Eris has opted for inorganic route to diversify and scale up expect margins to scale up from the current level of 35% as revenue scales up from recent acquisitions, which are currently operating at sub-optimal profitability. The company has multiple growth levers such as broad-based...

Eris Lifesciences Ltd.'s price crossed below 30Day SMA today

Eris Lifesciences Ltd.

19 May 2025

1615.40

-0.77%

Company Update

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Recording of Investor Call

pdf

Eris Lifesciences Ltd.

19 May 2025

1615.40

-0.77%

Company Update

Eris Lifesciences Ltd - 540596 - Revision In Outcome Of Board Meeting

BSE India

Revision in Outcome of Board Meeting

pdf

Eris Lifesciences Ltd.

19 May 2025

1615.40

-0.77%

Result

Eris Lifesciences Ltd - 540596 - Financial Results For Quarter And Year Ended March 31, 2025

BSE India

Financial results

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	713.25	731.67	566.07	-2.5%	26.0%
Operating Profit Qtr	252.39	250.31	148.43	0.8%	70.0%
Net Profit Qtr	93.84	83.63	70.96	12.2%	32.2%
Earning Per Share Adjusted latest Qtr	6.89	6.14	5.21	12.2%	32.2%

* Consolidated data

Detailed Results

Eris Lifesciences Ltd.

19 May 2025

1615.40

-0.77%

Investor Presentation

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor presentation

pdf

Eris Lifesciences Ltd.

19 May 2025

1615.40

-0.77%

Board Meeting

Eris Lifesciences Ltd - 540596 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Outcome of Board Meeting

pdf

Eris Lifesciences Ltd.

19 May 2025

1615.40

-0.77%

Lower-than-est. 4Q due to supply disruption for select products

Neutral: Eris Lifesciences Ltd.

Target

Motilal Oswal

Eris Lifesciences (ERIS) posted lower-than-expected 4QFY25 performance. This has been largely due to a marginal slip in the execution, particularly in the insulin revenue.